148 related articles for article (PubMed ID: 3865972)
1. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
[No Abstract] [Full Text] [Related]
2. Serum CA 125 levels in preoperative evaluation of pelvic masses.
Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
[No Abstract] [Full Text] [Related]
5. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
[TBL] [Abstract][Full Text] [Related]
6. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
Ishiwata I; Ishiwata C
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
[No Abstract] [Full Text] [Related]
7. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
8. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
[No Abstract] [Full Text] [Related]
9. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
10. [Significance of a new tumor marker for breast carcinoma and ovarian carcinoma].
Hoffmann L
Dtsch Med Wochenschr; 1987 May; 112(21):847-9. PubMed ID: 3472869
[No Abstract] [Full Text] [Related]
11. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
13. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
[TBL] [Abstract][Full Text] [Related]
14. CA-125 and uterine leiomyomas.
Scarpellini F; Minozzi M; Curto C; Scarpellini L
Acta Eur Fertil; 1993; 24(2):75-6. PubMed ID: 8171926
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
[No Abstract] [Full Text] [Related]
19. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
Canney PA; Wilkinson PM; James RD; Moore M
Br J Cancer; 1985 Jul; 52(1):131-3. PubMed ID: 2410004
[No Abstract] [Full Text] [Related]
20. [Monoclonal antibodies in the radioimmunological diagnosis of malignant tumors of the gastrointestinal tract and ovaries].
Tkacheva GA; Blokhina NG; Klimenkov AA; Kozachenko VP
Vopr Onkol; 1985; 31(5):36-42. PubMed ID: 2409674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]